Keep track of stocks that matter to you.
Help yourself to watchlist simple and free-new service from the idiot today.
Although we believe not on the market or panic on the market movements, we like to keep an eye on the big changes - just in case they are investing our thesis material.
Ce : Shares of nutritional products company Martek Biosciences (Nasdaq: MATK) fell by 10% today after the company earnings and referral.
So this: The most recent quarter reveal too bad, turning to monte 119,1 million revenue and adjusted earnings per share of $0.41 topped estimates. What investors are focusing on is the guidance for the quarter next $ 0.38 to $ 0.40 on the income of $ 110 million - on the low side of expectations 106 million.
Now what: The market is distributing a drubbing after what looks like a very nice neighbourhood. Direction was not totally out of line and taking into account the increase in sales, I think today provides an opportunity to pleasant purchase for investors. This Fool thought with ratio price/earnings before the 13 Martek, there is considerable potential growth for the company.
You are interested in more info about Martek Biosciences? Add to your list of tracking.
No comments:
Post a Comment